Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | CCR4 |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 1159266-37-1 |
ATC code | None |
Chemical data | |
Formula | C6520H10072N1736O2020S42 |
Mol. mass | 146.44 kDa |
(verify) |
(what is this?)
Mogamulizumab is a humanized monoclonal antibody designed for the treatment of cancers.
Mogamulizumab was developed by Kyowa Hakko Kirin Co., Ltd.[1]